ATE90791T1 - Mittel zum nachweis von gehirnkrankheiten in zusammenhang mit nervenscheidenmarkzerstoerung, insbesondere sklerosis multiplex. - Google Patents

Mittel zum nachweis von gehirnkrankheiten in zusammenhang mit nervenscheidenmarkzerstoerung, insbesondere sklerosis multiplex.

Info

Publication number
ATE90791T1
ATE90791T1 AT90402399T AT90402399T ATE90791T1 AT E90791 T1 ATE90791 T1 AT E90791T1 AT 90402399 T AT90402399 T AT 90402399T AT 90402399 T AT90402399 T AT 90402399T AT E90791 T1 ATE90791 T1 AT E90791T1
Authority
AT
Austria
Prior art keywords
diseases related
brain diseases
detecting brain
sclerosis multiplex
nervous cord
Prior art date
Application number
AT90402399T
Other languages
English (en)
Inventor
Jean-Pierre Zanetta
Jean-Marie Warter
Sabine Kuchler
Guy Vincendon
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE90791T1 publication Critical patent/ATE90791T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/285—Demyelinating diseases; Multipel sclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/827—Lectins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/828—Protein A

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Air Bags (AREA)
  • Valve Device For Special Equipments (AREA)
  • Steering-Linkage Mechanisms And Four-Wheel Steering (AREA)
  • Steering Control In Accordance With Driving Conditions (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Ignition Installations For Internal Combustion Engines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fuses (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT90402399T 1989-09-06 1990-08-30 Mittel zum nachweis von gehirnkrankheiten in zusammenhang mit nervenscheidenmarkzerstoerung, insbesondere sklerosis multiplex. ATE90791T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8911667A FR2651581B1 (fr) 1989-09-06 1989-09-06 Moyens pour le diagnostic de neuropathies demyelinisantes, en particulier de la sclerose en plaques.
PCT/FR1990/000638 WO1991003737A1 (fr) 1989-09-06 1990-08-30 Moyens pour le diagnostic de neuropathies demyelinisantes, en particulier de la sclerose en plaques

Publications (1)

Publication Number Publication Date
ATE90791T1 true ATE90791T1 (de) 1993-07-15

Family

ID=9385190

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90402399T ATE90791T1 (de) 1989-09-06 1990-08-30 Mittel zum nachweis von gehirnkrankheiten in zusammenhang mit nervenscheidenmarkzerstoerung, insbesondere sklerosis multiplex.

Country Status (14)

Country Link
US (1) US5225352A (de)
EP (1) EP0416984B1 (de)
JP (1) JP3032290B2 (de)
AT (1) ATE90791T1 (de)
AU (1) AU648516B2 (de)
CA (1) CA2024731A1 (de)
DE (1) DE69001972T2 (de)
DK (1) DK0416984T3 (de)
ES (1) ES2057476T3 (de)
FI (1) FI921009A0 (de)
FR (1) FR2651581B1 (de)
IE (1) IE64042B1 (de)
NO (1) NO920852L (de)
WO (1) WO1991003737A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2679034A1 (fr) * 1991-07-10 1993-01-15 Centre Nat Rech Scient Determination de la malignite des cellules de tumeurs humaines ou animales, au moyen de lectines endogenes.
FR2689521B1 (fr) * 1992-04-03 1996-07-19 Bio Merieux Procede d'obtention et maintien d'une culture cellulaire viable, infectee par un virus associe a la sclerose en plaques, et produits biologiques derives de ladite culture.
FR2689520B1 (fr) 1992-04-03 1996-07-19 Bio Merieux Procede et milieu de culture pour l'obtention de cellules infectees par un virus associe a la sclerose en plaques.
DE69533863T2 (de) * 1994-02-04 2006-02-16 Bio Merieux MSRV1 Virus der mit Multipler Sklerose verbunden ist, seine nukleären Bestandteile und Verwendungen
FR2716198B1 (fr) * 1994-02-15 1996-04-19 Bio Merieux Facteur cytotoxique tel qu'associé à la sclérose en plaques, sa détection et sa quantification.
US7048906B2 (en) * 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6861053B1 (en) * 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US6562629B1 (en) 1999-08-11 2003-05-13 Cedars-Sinai Medical Center Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
FR2737500B1 (fr) 1995-08-03 1997-08-29 Bio Merieux Materiel viral et fragments nucleotidiques associes a la sclerose en plaques, a des fins de diagnostic, prophylactiques et therapeutiques
JP4226657B2 (ja) 1996-11-26 2009-02-18 ベーイーオー メリュー 診断、予防、及び治療のための、多発性硬化症に関連するウイルス性物質及びヌクレオチド断片
JPH11143616A (ja) 1997-11-10 1999-05-28 Sega Enterp Ltd 文字通信装置
WO2000007602A1 (en) * 1998-08-06 2000-02-17 The Johns Hopkins University School Of Medicine Compounds for altering cell surface sialic acids and methods of use therefor
US6762032B1 (en) * 1999-08-23 2004-07-13 Biocrystal, Ltd. Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-MS immune response
US6652566B2 (en) 2000-10-05 2003-11-25 Seacoast Technologies, Inc. Neurosurgical device for thermal therapy including spiral element
US7858602B2 (en) * 2000-10-16 2010-12-28 Rodriguez Victorio C Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging disorders due to oxidative stress and as growth factors of stem cells
WO2004034031A2 (en) * 2002-10-11 2004-04-22 The Regents Of The University Of California A method for diagnosis and prognosis of multiple sclerosis
US6947870B2 (en) * 2003-08-18 2005-09-20 Baker Hughes Incorporated Neural network model for electric submersible pump system
FI20155280A (fi) 2015-04-15 2016-10-16 Medicortex Finland Oy Aivovamman prognostisia ja diagnostisia glykaanipohjaisia biomarkkereita

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311686A (en) * 1979-04-30 1982-01-19 The Immunology Development Corporation Methodology for the immunodiagnosis of multiple sclerosis and/or malignant diseases from blood sample analysis
FR2618439B1 (fr) * 1987-07-21 1990-05-25 Strosberg Arthur Sequences d'amino-acides reproduisant au moins en partie la sequence des lectines animales et humaines, leurs procedes d'obtention, leurs applications diagnostiques et therapeutiques
CA1338878C (en) * 1988-04-14 1997-01-28 Glenn E. Nedwin 14-beta-gal mammalian lectins

Also Published As

Publication number Publication date
JPH05500858A (ja) 1993-02-18
FR2651581A1 (fr) 1991-03-08
JP3032290B2 (ja) 2000-04-10
US5225352A (en) 1993-07-06
ES2057476T3 (es) 1994-10-16
FI921009A0 (fi) 1992-03-06
EP0416984B1 (de) 1993-06-16
CA2024731A1 (fr) 1991-03-07
NO920852D0 (no) 1992-03-04
WO1991003737A1 (fr) 1991-03-21
AU648516B2 (en) 1994-04-28
DE69001972T2 (de) 1993-09-23
IE903190A1 (en) 1991-03-13
EP0416984A1 (de) 1991-03-13
DE69001972D1 (de) 1993-07-22
AU6421490A (en) 1991-04-08
FR2651581B1 (fr) 1994-05-13
DK0416984T3 (da) 1993-08-16
NO920852L (no) 1992-03-04
IE64042B1 (en) 1995-06-28

Similar Documents

Publication Publication Date Title
ATE90791T1 (de) Mittel zum nachweis von gehirnkrankheiten in zusammenhang mit nervenscheidenmarkzerstoerung, insbesondere sklerosis multiplex.
TR24305A (tr) Blok kopolimer, bunu yapma metodu, bunun diamin oencueleri, bu tip diaminleri yapm
ES520416A0 (es) Procedimiento para la obtencion de proteina heterologa.
ES2036737T3 (es) Procedimiento para la obtencion de mezclas farmaceuticas.
NO904291D0 (no) Fremgangsmaate for fremstilling av radiomerkede antikoagulerende peptider.
GR3036138T3 (en) A screening method for identifying ligands for target proteins
DK0948604T3 (da) Screeningsmetoder for forbindelser som binder til PYK2-polypeptidet
SE8403630D0 (sv) Humana proteiner
NO904292D0 (no) Fremgangsmaate for fremstilling av antikoagulerende peptider.
DK0764273T3 (da) Alfa B crystallin til anvendelse i diagnose og terapi af autoimmune sygdomme, især multipel sklerose
DE69016071D1 (de) Verfahren zur Augen-Diagnostik.
DE69015372D1 (de) Protein-testverfahren.
ES2176523T3 (es) Procedimiento para la deteccion de la enfermedad de alzheimer.
ATE86651T1 (de) Nichtalkalisches suessen von kohlenwasserstofffraktionen.
NO894880L (no) Fremgangsmaate for fremstilling av antikoagulerende peptider.
IT8321550A0 (it) Procedimento per la concia delle pelli.
FI844645L (fi) 1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar.
BR9007738A (pt) Metodo de tratamento de couros
DE69734890D1 (de) Rdgb-proteine
BR8304513A (pt) Composto,processo para sua preparacao,e fibra de poliester ou poliamida
NO951679L (no) Fibronektin-bindende protein, samt fremstilling derav
DE69009592D1 (de) Vorrichtung zur gegenseitigen Ausrichtung von verschieden farbigen Strahlbündeln und Visiereinrichtung, die diese Vorrichtung enthält.
ES2085926T3 (es) Procedimiento para la determinacion del factor de von willebrand.
ES524353A0 (es) Procedimiento para la preparacion de n-metil-n-bis-(3,4-dimetoxi-fenil-etil)-amina
PT8143Y (pt) Fitinha para solas de sapatos de juta ou canhamo

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee